1

2
Saleh Ahmed, Oscar Barba, Jason Bloxham, Graham Dawson, William Gattrell, John Kitchin, Neil Anthony Pegg, Imaad Saba, Shazia Sadiq, Colin Peter Sambrook Smith, Don Smyth, Amo G Steinig, Robin Wilkes, Bijoy Panicker, Paula Tavares, Matthew Cox, An Hu Li, Hanqing Dong, Lifu Ma, Kenneth, Qinghua, Kathryn Stolz: Substituted pyrrolo[2.3-B]pyridines. OSI Pharmaceuticals, December 16, 2008: US07465726 (4 worldwide citation)

Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3β, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animal ...


3
Graham Michael Wynne, Kevin Doyle, Saleh Ahmed, An Hu Li, John Fraser Keily, Chrystelle Marie Rasamison, Neil Anthony Pegg, Imaad Saba, Claire Thomas, Don Smyth, Shazia Sadiq, Gary Newton, Graham Dawson, Andrew Phillip Crew, Arlindo Lucas Castelhano: (2-carboxamido)(3-amino)thiophene compounds. Osi Pharmaceuticals, September 23, 2004: US20040186124-A1

Compounds represented by Formula (I): 1 or a pharmaceutically acceptable salt or N-oxide thereof, wherein R1 is 2 R2 is 3 and R3 is C0-4alkyl, are useful in the treatment of cancer.


4
Saleh Ahmed, Celine Combet, Scott Cuthill, Graham Dawson, William Gattrell, Mario Lobell, Neil Pegg, Imaad Saba, Simon Swain, Claire Thomas, Graham Wynne: Mercaptoamides as histone deacetylase inhibitors. Osi Pharmaceuticals, March 2, 2006: US20060047123-A1

Mercaptoamide compounds, represented by Formulas (IA), (IB), (IIA), and (IIB): or a pharmaceutically acceptable salt thereof, inhibit histone deacetylase enzyme and are useful for the treatment and/or prevention of various infections, cancerous diseases, and conditions.


5
Saleh Ahmed, Oscar Barba, Jason Bloxham, Graham Dawson, Wiliam Gattrell, John Kitchin, Neil Anthony Pegg, Imaad Saba, Shazia Sadiq, Colin Peter Sambrook Smith, Don Smyth, Amo G Steing, Robin Wilkes, Bijoy Panicker, Paula Tavares, Matthew Cox, An Hu Li, Hanqing Dong, Lifu Ma, Kenneth, Qinghua, Kathryn Stolz: Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds. Osi Pharmaceuticals, September 21, 2006: US20060211678-A1

Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3β, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animal ...